Literature DB >> 21976738

Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy.

Zhen Qu1, Gang Liu, Jun Li, Li-hua Wu, Ying Tan, Xin Zheng, Jie Ao, Ming-hui Zhao.   

Abstract

BACKGROUND: The renal pathological manifestations of malignancy-associated membranous nephropathy (M-MN) and idiopathic membranous nephropathy (I-MN) are similar. It has been suggested that glomerular IgG4 deposition may play an important role in the pathogenesis of I-MN. In the present study, we compared the IgG subclass of immune complex deposition, clinical data and pathological data of patients with M-MN and I-MN.
METHODS: Eight patients with M-MN and 42 patients with I-MN diagnosed between 1997 and 2009 in our hospital were enrolled. The clinical and pathological data were retrospectively collected, and glomerular IgG subclass deposition was detected by immunohistochemistry.
RESULTS: Patients with M-MN were older (P = 0.003), with lower serum albumin (P = 0.034) and higher serum C-reactive protein (CRP) level (P = 0.003) than patients with I-MN. The majority of patients with M-MN had earlier pathological stages (P = 0.003) and less IgG deposition in glomeruli (P = 0.029). Absence of IgG4 deposition in glomeruli was notably observed in patients with M-MN (7/8 in M-MN versus 6/42 in I-MN, P < 0.001) and it was an independent predictor for occurrence of malignancy (hazard ratio 0.065, 95% confidence intervals 0.007-0.571, P = 0.014).
CONCLUSION: Absence of glomerular IgG4 deposition, together with older age, severe hypoalbuminemia and high serum CRP level could be useful clues to differentiate M-MN from I-MN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976738     DOI: 10.1093/ndt/gfr534

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  32 in total

1.  A case of gefitinib-associated membranous nephropathy in treatment for pulmonary adenocarcinoma.

Authors:  Tomohiro Kaneko; Akira Shimizu; Michiko Aoki; Shuichi Tsuruoka
Journal:  CEN Case Rep       Date:  2014-07-18

2.  IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.

Authors:  Carmen Lefaucheur; Denis Viglietti; Carol Bentlejewski; Jean-Paul Duong van Huyen; Dewi Vernerey; Olivier Aubert; Jérôme Verine; Xavier Jouven; Christophe Legendre; Denis Glotz; Alexandre Loupy; Adriana Zeevi
Journal:  J Am Soc Nephrol       Date:  2015-08-20       Impact factor: 10.121

3.  Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.

Authors:  Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

Review 4.  Immunopathogenesis of membranous nephropathy: an update.

Authors:  Hanna Debiec; Pierre Ronco
Journal:  Semin Immunopathol       Date:  2014-04-09       Impact factor: 9.623

Review 5.  Treatment of idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Fernando C Fervenza; Jack F M Wetzels
Journal:  Nat Rev Nephrol       Date:  2013-07-02       Impact factor: 28.314

6.  Membranous glomerulonephritis with crescents.

Authors:  Caroline M F Barrett; Megan L Troxell; Christopher P Larsen; Donald C Houghton
Journal:  Int Urol Nephrol       Date:  2013-11-12       Impact factor: 2.370

7.  Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.

Authors:  Norifumi Hayashi; Shin'ichi Akiyama; Hiroshi Okuyama; Yuki Matsui; Hiroki Adachi; Hideki Yamaya; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

8.  Concurrent isolated IgG2-positive membranous nephropathy and malignant B-cell lymphoma.

Authors:  Satoshi Shimada; Takashi Nakamichi; Gen Yamada; Kaori Narumi; Hajime Usubuchi; Tae Yamamoto; Satoshi Ichikawa; Noriko Fukuhara; Mariko Miyazaki; Hideo Harigae; Hiroshi Sato; Sadayoshi Ito
Journal:  CEN Case Rep       Date:  2018-05-15

Review 9.  Glomerular diseases: membranous nephropathy--a modern view.

Authors:  Claudio Ponticelli; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

Review 10.  The role of complement in membranous nephropathy.

Authors:  Hong Ma; Dana G Sandor; Laurence H Beck
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.